a clinial study to evaluate the the effect of purgation with Trivritadi kwath and drug effect with avipattikar churna in the management of Heart Burning in Acidity.
Phase 2/3
Not yet recruiting
- Conditions
- Gastro-esophageal reflux disease without esophagitis,
- Registration Number
- CTRI/2019/09/021295
- Lead Sponsor
- Choudhary brahm prakash charak ayurveda sansthana
- Brief Summary
the study is open label parallel group trail comparing the efficacy of virechana karma with trivritadi kwath and avipattikar churn in the management of amalapitta.dose of trivritadi kwath is according to kostha and dose of avipttikar churn is 5 gm bd 15 days.the trial will be conducted in chaudhary brahm prakash ayurveda charak sansthan khera dabar with primary outcome on symptom of amalpitta.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
- 1.Patients of either gender diagnosed as a case of Amalpitta and undergoing Virechana or Shamana chikitsa as per SOP.
- 2.Patients between age group of 20-50yrs.
Exclusion Criteria
- 1.Patients reporting with complications like Cardiac problems, emphysema, carcinoma, etc.
- will be excluded.
- 2.Pregnant woman and lactating mothers will be excluded.
- •Patient taking anti-inflammatory medications.
- •Patients of severe vomiting and dehydration 7 1 Patients with gastric malignancy 2 Patients who recently undergone gastrointestinal surgery.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduce in symptoms of Amalpitta 15 days
- Secondary Outcome Measures
Name Time Method Reduce in symptoms of amalpitta 15 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Trivritadi Kwath's efficacy in amalapitta management?
How does Avipattikar Churna compare to standard-of-care for gastro-esophageal reflux disease without esophagitis?
Are there specific biomarkers that predict response to Virechan Karma in acid peptic disorder?
What adverse events are associated with Trivritadi Kwath and Avipattikar Churna in clinical trials?
What combination therapies show promise in managing retrosternal burning symptoms in acidity?
Trial Locations
- Locations (1)
Ch.brahm prakash ayurvadic charak sathan new delhi
🇮🇳West, DELHI, India
Ch.brahm prakash ayurvadic charak sathan new delhi🇮🇳West, DELHI, IndiaDr Arun guptaPrincipal investigatorarun24@hotmail.com